Non-Hodgkin Lymphoma

“Nobody’s going to fight for your life the way you’re going to fight for your life,” Hodgkin’s lymphoma survivor, Paula Ngon, told CURE®.

Breyanzi has reportedly shown promising effects for patients with relapsed or refractory follicular lymphoma and B-cell non-Hodgkin lymphoma.

After going through grueling cancer treatments, I thought I’d never be back to my old self again. But thankfully, that wasn’t the case.

In 2022, I was diagnosed with cancer at 23 years old. Here’s what I’ve learned since.

From actress and journalist Maria Menounos opening up about her pancreatic diagnosis to the Pennsylvania governor signing a bill for free screenings, here’s what’s happening in the oncology space this week.

While certain gut microbiota may affect how a patient with lymphoma may response to CAR-T cell therapy, far more work is needed to better understand the connection.

While I wouldn’t say that my cancer-related hospital stays were fun, I did my best to maintain a positive attitude and make the best of them.

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

Hodgkin lymphoma survivors should avoid associated risk factors of developing colorectal cancer such as smoking, alcohol usage and being overweight.

I finally finished cancer treatment, and for the first time in a while, tomorrow feels more certain.

Combining maveropepimut-S plus Keytruda showed promising outcomes in a small group of patients with diffuse large B-cell lymphoma, study results showed.

I have only one more chemotherapy treatment left, but instead of being excited, I’m afraid that this final brutal treatment may be the end of me.

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

I exercised and ate healthy, yet still received a cancer diagnosis, leaving me wondering, “why me?”

From the cancer diagnoses of an MLB pitcher and star of Riverdance to First Lady Jill Biden’s recent carcinoma removal, here’s what’s happening in the cancer space this week.

Rickey and Marla Briskman’s marriage has grown as both have navigated the roles of patient with cancer and caregiver.

Tobacco smoke, pesticides, herbicides and chemicals in the air are among the substances that are known to increase the risk of getting some kinds of cancer.

From investigative journalist, Drew Griffin’s cancer-related death to Jane Fonda’s lymphoma update, here’s what’s happening in the oncology space this week.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.

From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.

Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

Spring 2022 brought in some landmark blood cancer approvals from the FDA. Here is a roundup of the therapies recently approved by the FDA that patients may have missed.

From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.

The use of bendamustine and Rituxan plus autologous stem cell transplantation and maintenance Rituxan resulted in similar outcomes to other Rituxan-based regimens that are currently the standard of care for young patients with mantle cell lymphoma, a type of non-Hodgkin lymphoma, who are eligible for transplant.

An expert gives an overview of current standard of care and what’s coming down the pipeline in terms of treatment options for diffuse large B-cell lymphoma.

Treatment with TRPH-222 led to lasting responses in certain patients with relapsed/refractory B-cell non-Hodgkin lymphomas, warranting a larger investigation into the drug, according to the researchers.

Nina Luker has shared her journey with diffuse large B-cell lymphoma on social media with more than 100,000 followers, but says she noticed a difference in the kinds of comments she received after treatment was over and she was deemed “not as vulnerable” anymore.